NCT02224560: Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
- State
- Completed
- Phase
- Phase 3
- People
- 225 taking part
- Started
- 8 Jun 2015
- Primary completion
- 19 May 2016
- Arms
- GWP42003-P 20 mg/kg/day Dose, GWP42003-P 10 mg/kg/day Dose
- Results
- Posted on the registry
- Papers
- doi:10.1002/14651858.cd003277.pub4, doi:10.1007/s40263-025-01201-8, doi:10.1056/nejmoa1714631, doi:10.1111/epi.16878, doi:10.1111/epi.17618, doi:10.1177/1535759719835671
- 25 Aug 2014: Trial registered
- 8 Jun 2015: Trial started
- 19 May 2016: Trial completed
- 27 Jul 2018: Trial results posted